AKBA icon

Akebia Therapeutics
AKBA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5.5
274% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
BTIG
BTIG
Julian Harrison
0% 1-yr AKBA win rate
2 Dec ‘25 20 hours ago
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
0% 1-yr AKBA win rate
2 Dec ‘25 yesterday